Document ID: FDA-2023-N-0013-0003
Agency: fda
Document Type: Notice
Title: Statement of Organization, Functions, and Delegations of Authority
Posted Date: 2023-03-02T05:00Z

[Federal Register Volume 88, Number 41 (Thursday, March 2, 2023)]
[Notices]
[Page 13126]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04009]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Statement of Organization, Functions, and Delegations of 
Authority

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Secretary of Health and Human Services delegates to the 
Food and Drug Administration (FDA) Commissioner the authorities vested 
in the Secretary of Health and Human Services (the Secretary) under 
section 3855 of the Coronavirus Aid, Relief, and Economic Security 
(CARES) Act, as amended, to send annual letters to Congress regarding 
the progress of FDA in: evaluating the Over-the-Counter Monograph M012: 
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products 
for Over-the-Counter Human Use with respect to children under the age 
of 6, and as appropriate, revising that monograph through the order 
process of section 505G(b) of the Federal Food, Drug, and Cosmetic Act 
to address such children. These authorities may be redelegated. 
Exercise of this authority shall be in accordance with established 
policies, procedures, guidelines, and regulations as prescribed by the 
Secretary.

DATES: This authority delegation was approved by the Secretary on 
February 22, 2023.

    Dated: February 22, 2023.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2023-04009 Filed 3-1-23; 8:45 am]
BILLING CODE 4164-01-P